نتایج جستجو برای: os trigonum syndrome

تعداد نتایج: 728792  

Journal: :Psychoneuroendocrinology 2015
Xiang Yang Zhang Da-Chun Chen Yun-Long Tan Shu-Ping Tan Zhi-Ren Wang Fu-De Yang Olaoluwa O Okusaga Giovana B Zunta-Soares Jair C Soares

Neurodegenerative processes may be involved in the pathogenesis of schizophrenia. Brain-derived neurotrophic factor (BDNF), the most widely distributed neurotrophin and oxidative stress (OS) may be critical for several pathological manifestations of neurodegenerative disorders. Accumulating evidence suggests that both BDNF and OS may be involved in the pathophysiology of schizophrenia. However,...

2014
Hilary C. Martin Grace E. Kim Alistair T. Pagnamenta Yoshiko Murakami Gemma L. Carvill Esther Meyer Richard R. Copley Andrew Rimmer Giulia Barcia Matthew R. Fleming Jack Kronengold Maile R. Brown Karl A. Hudspith John Broxholme Alexander Kanapin Jean-Baptiste Cazier Taroh Kinoshita Rima Nabbout David Bentley Gil McVean Sinéad Heavin Zenobia Zaiwalla Tony McShane Heather C. Mefford Deborah Shears Helen Stewart Manju A. Kurian Ingrid E. Scheffer Edward Blair Peter Donnelly Leonard K. Kaczmarek Jenny C. Taylor

In severe early-onset epilepsy, precise clinical and molecular genetic diagnosis is complex, as many metabolic and electro-physiological processes have been implicated in disease causation. The clinical phenotypes share many features such as complex seizure types and developmental delay. Molecular diagnosis has historically been confined to sequential testing of candidate genes known to be asso...

2015
Sebastian Ribi Daniel Baumhoer Kristy Lee Edison Audrey S.M. Teo Babita Madan Kang Zhang Wendy K. Kohlmann Fei Yao Wah Heng Lee Qiangze Hoi Shaojiang Cai Xing Yi Woo Patrick Tan Gernot Jundt Jan Smida Michaela Nathrath Wing-Kin Sung Joshua D. Schiffman David M. Virshup Axel M. Hillmer

Somatic mutations of TP53 are among the most common in cancer and germline mutations of TP53 (usually missense) can cause Li-Fraumeni syndrome (LFS). Recently, recurrent genomic rearrangements in intron 1 of TP53 have been described in osteosarcoma (OS), a highly malignant neoplasm of bone belonging to the spectrum of LFS tumors. Using whole-genome sequencing of OS, we found features of TP53 in...

2016
Tao Zuo Minghui Zhu Wenming Xu

Oxidative stress (OS) has received extensive attention in the last two decades, because of the discovery that abnormal oxidation status was related to patients with chronic diseases, such as diabetes, cardiovascular, polycystic ovary syndrome (PCOS), cancer, and neurological diseases. OS is considered as a potential inducing factor in the pathogenesis of PCOS, which is one of the most common co...

2016
Kai Homer Kady Fischer Dominik P Guensch Nancy Shie Julie Lebel François Roubille Matthias G Friedrich

Background Oxygenation-sensitive cardiovascular magnetic resonance (OS-CMR) relies on the attenuating effects of deoxyhemoglobin as an intrinsic contrast. When using OS-CMR to assess myocardial oxygenation, failing to account for effects on myocardial oxygen-sensitive signal intensity (OS-SI) due to arterial hemoglobin desaturation could confound results attributed to changes in perfusion and t...

2016
Hernán Gonzalo Villagarcía Vanesa Sabugo María Cecilia Castro Guillermo Schinella Daniel Castrogiovanni Eduardo Spinedi María Laura Massa Flavio Francini

We investigated the impact of chronic hypercorticosteronemia (due to neonatal monosodium L-glutamate, MSG, and treatment) on liver oxidative stress (OS), inflammation, and carbohydrate/lipid metabolism in adult male rats. We evaluated the peripheral concentrations of several metabolic and OS markers and insulin resistance indexes. In liver we assessed (a) OS (GSH and protein carbonyl groups) an...

Journal: :Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2015
Chan Shen Ya-Chen Tina Shih Ying Xu James C Yao

BACKGROUND Octreotide long-acting repeatable (LAR) is approved in the United States for the management of carcinoid syndromes among patients with neuroendocrine tumors (NET). The objective of our study is to evaluate the impact of octreotide LAR on overall survival (OS), as it has not been established. METHODS NET patients of 65 years and older diagnosed between January 1999 and December 2009...

2015
Elena Maccaroni Raffaella Bracci Riccardo Giampieri Francesca Bianchi Laura Belvederesi Cristiana Brugiati Silvia Pagliaretta Michela Del Prete Mario Scartozzi Stefano Cascinu

BACKGROUND Lynch syndrome (LS) is the most common hereditary colorectal cancer (CRC) syndrome, caused by germline mutations in MisMatch Repair (MMR) genes, particularly in MLH1, MSH2 and MSH6. Patients with LS seem to have a more favourable prognosis than those with sporadic CRC, although the prognostic impact of different mutation types is unknown. Aim of our study is to compare survival outco...

2015
Yu Zheng Fuli Wang Guojun Wu Longlong Zhang Yangmin Wang Zhiping Wang Peng Chen Qing Wang Jingyi Lu Yujie Wang Peijun Li Jian Wang Xitao Lu Jianlin Yuan

The aim of the study is to evaluate the relationship between the adverse events and efficacy of sorafenib in patients with metastatic renal cell carcinoma (mRCC), with a purpose to guide the judgment of efficacy in sorafenib treatment.Eighty-three mRCC patients who received sorafenib therapy at northwest China were studied retrospectively. Univariate and multivariate analyses were performed to ...

Journal: :international journal of hematology-oncology and stem cell research 0
ardeshir ghavamzadeh hematology- oncology and stem cell transplantation research center, shariati hospital, tehran university of medical sciences, tehran, iran atefeh masnavi hematology- oncology and stem cell transplantation research center, shariati hospital, tehran university of medical sciences, tehran, iran farnaz khatami hematology- oncology and stem cell transplantation research center, shariati hospital, tehran university of medical sciences, tehran, iran arash jalali hematology- oncology and stem cell transplantation research center, shariati hospital, tehran university of medical sciences, tehran, iran mohammad jahani hematology- oncology and stem cell transplantation research center, shariati hospital, tehran university of medical sciences, tehran, iran masoud iravani hematology- oncology and stem cell transplantation research center, shariati hospital, tehran university of medical sciences, tehran, iran

introduction: the traditional goal of the treatment of acute myelogenous leukemia is to produce and maintain a complete remission (cr).the difference in survival time was entirely attributable to the duration of time spent in cr .in this study, the outcome of aml patients with allogeneic hsct in cr1 versus other than cr1 was compared. patients and methods: since march 1991 until november 2008, ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید